
04/08/2025
Breaking new ground in diabetic retinopathy screening! Optomed US and AEYE Health’s Aurora with AI just received FDA clearance—the first handheld AI diabetic retinopathy screening device in the US. Fast, non-invasive, and ready to deliver results in just 60 seconds, it’s expected to transform patient care and expand access like never before. Get the full details here. https://piemagazine.org/fda-approved-first-diabetic-retinopathy-screening-device/
The Aurora AEYE is the first FDA-approved handheld AI fundus camera. Optomed (Helsinki, Finland) has announced that its handheld fundus...